Explore /
Poster
/ Patterns of presentation and delivery of care of appendiceal neoplasms in the largest municipal health care delivery system in the United States.

Patterns of presentation and delivery of care of appendiceal neoplasms in the largest municipal health care delivery system in the United States.

Authors

Armaan Ahmed

Johns Hopkins University, Baltimore, MD

Armaan Ahmed , Jennifer Whittington , Zahra Shafaee

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Cancer Disparities

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 14)

DOI

10.1200/JCO.2024.42.3_suppl.14

Abstract #

14

Poster Bd #

B15

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Annual Meeting

REPROGRAM-02: A phase II-III study evaluating an induction treatment with regorafenib and metronomic chemotherapy before the second line chemotherapy in metastatic colorectal cancer.

REPROGRAM-02: A phase II-III study evaluating an induction treatment with regorafenib and metronomic chemotherapy before the second line chemotherapy in metastatic colorectal cancer.

First Author: Angelique Vienot

Poster

2023 ASCO Annual Meeting

Integration of trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2 positive gastric (GC) and esophagogastric junction cancer (EGJC): First results of the EORTC 1203 INNOVATION study, in collaboration with the Korean Cancer Study Group, and the Dutch Upper GI Cancer group.

Integration of trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2 positive gastric (GC) and esophagogastric junction cancer (EGJC): First results of the EORTC 1203 INNOVATION study, in collaboration with the Korean Cancer Study Group, and the Dutch Upper GI Cancer group.

First Author: Anna Dorothea Wagner

Poster

2015 ASCO Annual Meeting

PRODIGE 20: Bevacizumab + chemotherapy (BEV-CT) versus chemotherapy alone (CT) in elderly patients (pts) with untreated metastatic colorectal cancer (mCRC)—A randomized phase II trial.

PRODIGE 20: Bevacizumab + chemotherapy (BEV-CT) versus chemotherapy alone (CT) in elderly patients (pts) with untreated metastatic colorectal cancer (mCRC)—A randomized phase II trial.

First Author: Thomas Aparicio

Poster

2014 Gastrointestinal Cancers Symposium

Cost differential among systemic therapies for colon cancer.

Cost differential among systemic therapies for colon cancer.

First Author: Hasan Nadeem